Concepedia
Statistics
Publications
6
Citations
784
H-Index
Active since
2016
Affiliations
Gilead Sciences (United States)(Current)
Texas Liver Institute
Inova Fairfax Hospital
The University of Texas at San Antonio Health Science Center
Chinese University of Hong Kong
Dora Ding is an author at Gilead Sciences (United States) specializing in medicine, liver disease, and chronic liver disease.
Publications per year
2016–2022
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba, Mazen Noureddin, Kris V. Kowdley et al. · Hepatology · 2020 · 278 citations
Medicine, Pharmacology, Pharmacotherapy +17
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
Andrew J. Muir, Cynthia Levy, Harry L.A. Janssen et al. · Hepatology · 2018 · 193 citations
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
Arun J. Sanyal, Quentin M. Anstee, Michael Trauner et al. · Hepatology · 2021 · 151 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Rohit Loomba, Daniel Q. Huang, Arun J. Sanyal et al. · Gut · 2022 · 98 citations · Full text
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
Eric Lawitz, Bal Raj Bhandari, Peter Ruane et al. · Clinical Gastroenterology and Hepatology · 2022 · 54 citations · Full text
1–5 of 6